Overview

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

Status:
Completed

Trial end date:
2013-06-03

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate the long-term maintenance of efficacy of Extended-Release Guanfacine HCl in children and adolescents (6-17 years) with attention-deficit/hyperactivity disorder (ADHD) who respond to an initial open-label, short term treatment with SPD503.

Phase:

Phase 3

Details

Lead Sponsor:

Shire

Treatments:

Guanfacine